Cancer cell 'degraders' target two proteins at once to defeat treatment resistance

Cancer cell 'degraders' target two proteins at once to defeat treatment resistance. Researchers from two Technion faculties have jointly developed a new compound and demonstrated its effectiveness against aggressive tumor cells.

A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: Researchers from two Technion faculties have jointly developed a new compound and demonstrated its effectiveness against aggressive tumor cells.

• Ponto de atenção: cancer.
• Ponto de atenção: cell.
• Ponto de atenção: degraders.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.